Evidence map›Paper›PMID 34466255›Full record

ArticleClinical case reports2021

Creutzfeldt-Jakob disease with neuroleptic malignant syndrome.

Julija Čiauškaitė, Ieva Puleikytė, Simonas Jesmanas, Giedrė Jurkevičienė, Antanas Vaitkus, Daiva Rastenytė

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Julija ČiauškaitėDepartment of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.ORCID 0000-0002-7361-7920
Ieva PuleikytėDepartment of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
Simonas JesmanasDepartment of Radiology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
Giedrė JurkevičienėDepartment of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
Antanas VaitkusDepartment of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
Daiva RastenytėDepartment of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.

Indexed as

atypical antipsychotic medicationsCreutzfeldt‐Jakob diseaseelectroencephalographymagnetic resonance imagingneuroleptic malignant syndromequetiapine

Identifiers

PMID34466255
PMCPMC8385257
OpenAlexW3193443695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.